Target intelligence / Profile preview

RNA, U1 small nuclear 131, pseudogene (RNU1-131P)

Target
RNU1-131P
Molecular classification
Other, Pseudogene, Small nuclear RNA gene family (non-coding RNA)
01

Overview

RNA, U1 small nuclear 131, pseudogene (RNU1-131P) is annotated as a pseudogene of the U1 small nuclear RNA (snRNA) family[9][1]. Pseudogenes are genomic DNA sequences similar to known genes but generally non-functional due to disruptions that prevent their normal expression or activity[3]. The U1 snRNA is a core component of the spliceosome, playing a critical role in pre-mRNA splicing[3][5], but RNU1-131P itself is not known to encode a functional RNA or protein, nor is it associated with any known disease role, therapeutic intervention, or molecular targeting. Unlike functional U1 snRNA genes, RNU1-131P is not considered a drug target and does not play a direct role in canonical biological pathways or disease mechanisms[9][1][3]. There is no evidence that this particular pseudogene is transcriptionally active, or exerts regulatory functions similar to some other recently described variant U1 snRNA pseudogenes[3]. Key context: - RNU1-131P is classified as a pseudogene, not a functional target or molecule for therapy[1][9]. - There is no indication of involvement in known biological functions or disease roles, and it is not targeted by drugs or used as a biomarker[1][9]. - Some U1 snRNA pseudogenes have been shown to be transcriptionally active and potentially exert regulatory functions[3][4], but there is no evidence that RNU1-131P itself is one of these cases[9][1]. Therefore, this entry is not a correct or useful molecular target for therapeutic or biomarker purposes.

Other names
RNU1-131PRNA, U1 small nuclear 131 pseudogene

Beyond the preview

Go deeper on RNA, U1 small nuclear 131, pseudogene (RNU1-131P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 131, pseudogene (RNU1-131P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call